Clinical trials update from the European Society of Cardiology Heart Failure Meeting 2010: TRIDENT 1, BENEFICIAL, CUPID, RFA-HF, MUSIC, DUEL, handheld BNP, phrenic nerve stimulation, CHAMPION and CABG with CRT study

European Journal of Heart Failure

Volumn 12, Issue 8, 2010, Pages 883-888

  Cleland, John G F ^a   Coletta, Alison P ^a   Clark, Andrew L ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Heart failure; Randomized controlled trials

Indexed keywords

3 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)BICYCLO[2.2.2]OCTAN 1 YL]PROPIONIC ACID; ALAGEBRIUM; CALCIUM; DIURETIC AGENT; FUROSEMIDE; PROTEIN SERCA 2 A; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TONAPOFYLLINE; TORASEMIDE; UNCLASSIFIED DRUG;

CARDIAC RESYNCHRONIZATION THERAPY; CENTRAL SLEEP APNEA SYNDROME; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; DRUG SAFETY; EXERCISE; GENE THERAPY; GENETIC TRANSFECTION; GLYCATION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART FUNCTION; HUMAN; KIDNEY FAILURE; LUNG ARTERY PRESSURE; MEDICAL SOCIETY; MORTALITY; NERVE STIMULATION; PATIENT CARE; PHRENIC NERVE; POINT OF CARE TESTING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SLEEP APNEA SYNDROME; UPREGULATION;

EID: 77955453178     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq128     Document Type: Conference Paper

References (24)

1. Vallon V, Miracle C, Thomson S. Adenosine and kidney function: potential implications in patients with heart failure. Eur J Heart Fail 2008;10:176-187.
2. Coletta AP, Tin L, Loh H, Clark AL, Cleland JGF. Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902. Eur J Heart Fail 2006;8:547-549.
3. Cleland JGF, Coletta AP, Yassin A, Hado H, Cullington D, Abdellah AT, Clark AL. Clinical trials update from the American College of Cardiology 2008: CARISMA, TRENDS, meta-analysis of cyclo-oxygenase-2 data, HAT, studies related to hypertension, MOMENTUM, PROTECT, HORIZON-HF and REVERSE. Heart Fail 2008;10:614-620.
4. Cotter G, Dittrich HC,Weatherley BD, Bloomfield DM, O'Connor CM, Metra M, Massie BM, for the PROTECT steering committee, investigators. The PROTECT pilot study: a randomised placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. J Card Fail 2008;14:631-640.
5. Cleland JGF, Coletta AP, Yassin A, Buga L, Torabi A, Clark AL. Clinical trials update from the European Society of Cardiology Meeting 2009: AAA, RELY, PROTECT, ACTIVE-I, European CRT survey, German pre-SCD II registry and MADIT-CRT. Heart Fail 2009;11:1214-1219.
6. Hartog JWL, Voors AA, Bakker SJL, Smit AJ, van Veldhuisen DJ. Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications. Eur J Heart Fail 2007;9:1146-1155.
7. Willemsen S, Hartog JWL, Hummel YM, Posma JL, Van Wijk LM, van Veldhuisen DJ, Voors AA. Effects of alagebrium, an advanced glycation endproduct breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial. Eur J Heart Fail 2010;12:294-300.
8. Cleland JGF, Coletta AP, Buga L, Ahmed D, Clark AL. Clinical trials update from the American College of Cardiology Meeting 2010: DOSE, ASPIRE, CONNECT, STICH, STOP-AF, CABANA, RACE II, EVEREST II, ACCORD and NAVIGATOR. Heart Fail 2010;12:623-629.
9. Shelton RJ, Clark AL, Goode K, Rigby AS, Houghton T, Kaye GC, Cleland JGF. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II study). Heart 2009;95: 924-930.
10. Thackray SD, Wright GA, Witte KK, Nikitin NP, Tweddel AC, Clark AL, Cleland JG. The effect of ventricular pacing on measurements of left ventricular function: a comparison between echocardiographic methods and with radionuclide ventriculography. Eur J Echocardiogr 2006;7:284-292.
11. Zhang J, Goode K, Cuddihy PE, Cleland JG, TEN-HMS Investigators. Predicting hospitalisation due to worsening heart failure using daily weight measurement: analysis of the Trans-European Network-Home-Care-Management system (TEN-HMS study). Eur J Heart Fail 2009;11:420-427.
12. Maisel A, Mueller C, Adams K, Anker SD, Aspromonte N, Cleland JGF, Cohen-Solal A, Dahlstrom U, DeMaria A, Di Somma S, Filippatos GS, Fonarow GC, Jourdain P, Komajda M, Liu PP, McDonagh T, McDonald K, Mebazza A, Nieminen MS, Peacock WF, Tubaro M, Valle R, Vanderhayden M, Yancy CW, Zannad F, Braunwald E. State of the art; using natriuretic peptide levels in clinical practice. Eur J Heart Fail 2008;10:824-839.
13. Javaheri S, Shukla R, Zeigler H, Wexler L. Central sleep apnea, right ventricular dysfunction and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 2007;49:2028-2034.
14. Wijkstra PJ, van Veldhuisen DJ. Central sleep apnoea: another important comorbidity in heart failure? Eur J Heart Fail 2010;12:309-310.
15. Oldenberg O, Lamp B, Faber L, Teschler H, Horstkotte D, Topfer V. Sleep disordered breathing in patients with heart failure. A contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 2007;9:251-257.
16. Khong P, Lazzaro A, Mobbs R. Phrenic nerve stimulation: the Australian experience. J Clin Neurosci 2010;17:205-208.
17. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
18. Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM, Magalski A, Zile MR, Smith AL, Smart FW, O'Shaughnessy MA, Jessup ML, Sparks B, Naftel DL, Stevenson LW, COMPASS-HF study group. Randomised controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol 2008;51: 1073-1079.
19. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, for the CARE-HF study investigators. The effect of cardiac resynchronisation on morbidity and mortality in heart failure. N Eng J Med 2005;352:1539-1549.
20. Van Veldhuisen DJ, Maas AH, Priori SG, Stolt P, van Gelder IC, Dickstein K, Swedberg K. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail 2009;11: 1143-1151.
21. Gras D, Bocker D, Lunati M, Wellens HJ, Calvert M, Freemantle N, Gervais R, Kappenberger L, Tavazzi L, Erdmann E, Cleland JG, Daubert JC, CARE-HF study steering committee, investigators. Implantation of cardiac resynchronisation therapy systems in the CARE-HF trial: procedural success rate and safety. Europace 2007;9:516-522.
22. Goscinka-Bis K, Bis J, Krejca M, Ulczok R, Szmagala P, Bochenek A, Kargul W. Totally epicardial cardiac resynchronisation therapy system implantation in patients with heart failure undergoing CABG. Eur J Heart Fail 2008;10:498-506.
23. Pokushalov E, Romanov A, Prohorova D, Cherniavsky A, Goscinka-Bis K, Bis J, Bochenek A, Karasov A. Coronary artery bypass grafting with concomitant cardiac resynchronisation therapy in patients with ischaemic heart failure and left ventricular dyssynchrony. Eur J Cardiothorac Surg 2010; doi 10.1016/j. ejcts.2010.03.036. Published online ahead-of-print 6 May 2010.
24. Coletta AP, Cleland JGF, Cullington D, Clark AL. Clinical trials update from heart rhythm 2008 and heart failure 2008: ATHENA, URGENT, INH study, HEART and CK-1827452. Heart Fail 2008;10:917-920.